When was Myocardial Solutions founded?

Myocardial Solutions was founded in 2002 and raised its 1st funding round 14 years after it was founded.

Where is Myocardial Solutions located?

Myocardial Solutions is headquartered in Morrisonville, United States. It is registered at Morrisville, North Carolina.

Who is the current CEO of Myocardial Solutions?

Clete Madden, Robert Kay and John Funkhouser s of Myocardial Solutions.

How many employees does Myocardial Solutions have?

As of Sep 30, 2026, the latest employee count at Myocardial Solutions is 31.

Is Myocardial Solutions a funded company?

Myocardial Solutions is a funded company, having raised a total of $29.9M across 6 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Jan 04, 2016.

When was the latest funding round of Myocardial Solutions?

Myocardial Solutions' latest funding was a $***** Series B round on Jun 29, 2023, with participation from 0 investor.

Where does Myocardial Solutions rank among its competitors?

Myocardial Solutions ranks 26th amongst 101 active competitors, of which 27 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was ViTAA Medical, which secured $4.87M in Jan, 2025.

Who are the top competitors of Myocardial Solutions?

Myocardial Solutions' top competitors include GEN inCode, Caristo Diagnostics and Proxim Diagnostics. Among them, ViTAA Medical secured the most recent funding round in January, 2025.

Myocardial Solutions - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of MRI-based diagnostic software for cardiac disease. It has developed three products SENC calculates cardiac strain in a single heartbeat, eliminating the need to hold the breath, HARP is an FDA-cleared software that automatically analyzes tagged MRI images and measures cardiac function and VIRTUE provides a suite of tools to view and analyze cardiac images.

Website: www.myocardialsolutions.com/
Social
Email ID: *****@myocardialsolutions.com
Registered Address: Morrisville, North Carolina

Key Metrics

Founded Year

2002

Location

Morrisonville, United States

Stage

Series B

Total Funding

$29.9M in 6 rounds

Latest Funding Round

Series B, Jun 29, 2023, $*****

Investors

Pond Capital

Ranked

26^th among 101 active competitors

Employee Count

31 as on Sep 30, 2026

Similar Companies

GEN inCode & 133 more

View Myocardial Solutions' full profile

Myocardial Solutions is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
MYOCARDIAL SOLUTIONS, INC. CIN: 810849063 , United States, Active	Dec 26, 999	-	15 (As on Dec 31, 2024)	-

Myocardial Solutions has raised a total funding of $29.9M over 6 rounds. Its first funding round was on Jan 04, 2016. Myocardial Solutions has 1 institutional investor.

Here is the list of recent funding rounds of Myocardial Solutions:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 29, 2023	7317944	Series B	7473648	7747263	7797802	4692892
Mar 23, 2021	6143856	Series B	4040955	4218376	7767424	8682620
Mar 06, 2019	8151106	Series A	3180517	2773163	9356663	5898263

Access funding benchmarks and valuations. Sign up today!

View details of Myocardial Solutions's funding rounds and investors

The founders of Myocardial Solutions is Nael Osman. Clete Madden, Robert Kay and John Funkhouser are the CEOs of Myocardial Solutions.

Here are the details of Myocardial Solutions' key team members:

Nael Osman: Founder of Myocardial Solutions and founder of 1 other company. They serve on the board of 1 company.
Clete Madden: Co-CEO of Myocardial Solutions.
Robert Kay: Co-CEO of Myocardial Solutions.
John Funkhouser: Co-CEO of Myocardial Solutions.

Myocardial Solutions' Board of Directors

Myocardial Solutions's board has 12 active members. William Burke, Todd Robinson, Nael Osman, Dane Andreeff, Gary Brock, Timothy McLaughlin, Nelson R. Hill, Randy Hill, Todd A. Robinson, Denise McKenzie, John P. Funkhouser and Robert L. Kay are independent board members.

Here is the list of Myocardial Solutions' board of directors:

Name	Type	Representing	Status	Duration
William Burke	Independent board member	-	Current	9y 3m
reuy{xc	Independent board member	-	Current	9y 6m
wermho{	Independent board member	-	Current	9y 8m
lrfdwgu	Independent board member	-	Current	6y 2m
ktyzwuh	Independent board member	-	Current	1y 7m
zetzkna	Independent board member	-	Current	1y 7m
uatpnkz	Independent board member	-	Current	3y 4m
l{dedqj	Independent board member	-	Current	5y 6m
tweugdb	Independent board member	-	Current	3y 8m
mvkoxvu	Independent board member	-	Current	6y 6m
jszlitx	Independent board member	-	Current	2y 1m
yqwjhzu	Independent board member	-	Current	5y 8m

View details of Myocardial Solutions's Founder profiles and Board Members

Myocardial Solutions' employee count trend

Myocardial Solutions has 31 employees as of Sep 26. Here is Myocardial Solutions's employee count trend over the years:

Employee count trend for Myocardial Solutions

Uncover Myocardial Solutions' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Myocardial Solutions include GEN inCode, Caristo Diagnostics and Proxim Diagnostics. Here is the list of Top 10 competitors of Myocardial Solutions, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	GEN inCode 2018, Manchester (United Kingdom), Public	Developer of precison medicines by combining genetic and clinical data for cardiac disease monitoring	$5.46M	Downing, Maven Capital Partners & 4 others	60/100
2nd	Caristo Diagnostics 2017, Oxford (United Kingdom), Series A	Developer of technology for cardiac disease risk assessment and analysis	$18.9M	Oxford Science Enterprises, BGF & 19 others	58/100
3rd	Proxim Diagnostics 2010, Sunnyvale (United States), Series B	Developer of a handheld immunodiagnostic device for cardiac vascular diseases	$22.9M	BioMerieux, UCLA Ventures & 1 others	52/100
4th	SmartHealth 1979, Irvine (United States), Series B	Developer precision diagnostics for vascular, metabolic, and oncological diseases	$17.3M	-	50/100
5th	Epsilon Imaging 2008, Ann Arbor (United States), Series B	Advanced echo analysis software solutions improving cardiovascular care and workflow	$4.63M	ID Ventures, Ann Arbor Angels & 5 others	48/100
6th	Realview Imaging 2008, Yokneam Illit (Israel), Series C	Provides 3D holographic display based solutions for medical imaging applications	$25M	OurCrowd, ADIP & 10 others	46/100
7th	Prolight Diagnostics 2000, Lund (Sweden), Public	Provider of Point-of-Care systems for in-vitro diagnostic tests from a drop of blood	-	-	44/100
8th	Zora Biosciences 2016, Espoo (Finland), Funding Raised	Provider of diagnostic solutions for cardiovascular diseases and cancer	-	Voima Ventures, Europa	44/100
9th	ViTAA Medical 2019, Montreal (Canada), Series A	Developer of personalized medicine solutions for patients diagnosed with abdominal aortic aneurysms	$4.87M	-	44/100
10th	Diadexus 1997, San Francisco (United States), Acquired	Innovating clinical diagnostics with advanced enzyme and immunoassay technologies	$49.2M	Brookside Capital, Burrill and Company & 4 others	43/100
26th	Myocardial Solutions 2002, Morrisonville (United States), Series B	Provider of MRI-based diagnostic software for cardiac disease	$29.9M	Pond Capital	35/100